• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致恶性疟原虫疟疾贫血发展的因素:耐药寄生虫呢?

Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?

作者信息

Quashie Neils Ben, Akanmori Bartholomew D, Ofori-Adjei David, Goka Bamenla Q, Kurtzhals Jorgen A L

机构信息

Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, Accra, Ghana.

出版信息

J Trop Pediatr. 2006 Aug;52(4):254-9. doi: 10.1093/tropej/fmi110. Epub 2005 Dec 2.

DOI:10.1093/tropej/fmi110
PMID:16326751
Abstract

A major manifestation of complicated malaria especially among children is severe anaemia, the pathogenesis of which is not well understood. Among other factors, suppression of the bone marrow's response to erythropoietin, which is rapidly reversed after successful treatment of the malaria, has been implicated in its pathogenesis. Since resolution of malaria restores erythropoiesis, we hypothesized that drug-resistant strains of Plasmodium falciparum would increase the risk of severe anaemia developing from initially uncomplicated malaria. Using both in vivo and in vitro drug-sensitivity tests we compared the prevalence of drug-resistant malaria between severe malarial anaemia SA and non-anaemic malaria NAM patients. Assessment of treatment outcome using the WHO in vivo criteria showed no significant difference in parasite resistance between the two groups. The mean parasite clearance time was also comparable. Treatment failures of about 14 per cent and 12 per cent were observed between SA and NAM patients respectively. The in vitro drug susceptibility test showed overall mean IC50 values of 0.41x10(-6) mol/l and 0.32x10(-6) mol/l blood for SA and NAM groups respectively. Geometric mean pre-treatment blood levels of chloroquine did not differ much between the two groups. Findings from this study could not therefore implicate drug-resistant parasites in the pathogenesis of severe malarial anaemia.

摘要

复杂型疟疾的一个主要表现,尤其是在儿童中,是严重贫血,其发病机制尚不完全清楚。在其他因素中,骨髓对促红细胞生成素反应的抑制(在成功治疗疟疾后迅速逆转)被认为与其发病机制有关。由于疟疾的缓解可恢复红细胞生成,我们推测恶性疟原虫的耐药菌株会增加最初无并发症的疟疾发展为严重贫血的风险。我们使用体内和体外药敏试验,比较了严重疟疾贫血(SA)患者和非贫血性疟疾(NAM)患者中耐药疟疾的患病率。使用世界卫生组织的体内标准评估治疗结果显示,两组之间的寄生虫耐药性没有显著差异。平均寄生虫清除时间也相当。SA组和NAM组患者的治疗失败率分别约为14%和12%。体外药敏试验显示,SA组和NAM组的总体平均IC50值分别为0.41x10(-6)mol/l和0.32x10(-6)mol/l血液。两组之间氯喹的几何平均治疗前血药水平差异不大。因此,本研究的结果并不表明耐药寄生虫与严重疟疾贫血的发病机制有关。

相似文献

1
Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?导致恶性疟原虫疟疾贫血发展的因素:耐药寄生虫呢?
J Trop Pediatr. 2006 Aug;52(4):254-9. doi: 10.1093/tropej/fmi110. Epub 2005 Dec 2.
2
Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.尼日利亚恶性疟原虫感染儿童中,恶性疟原虫氯喹抗性转运蛋白和恶性疟原虫多药抗性1基因的突变与体内阿莫地喹抗性之间的关联。
Am J Trop Med Hyg. 2006 Jul;75(1):155-61.
3
Pretreatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment.
J Trop Pediatr. 2005 Jun;51(3):149-53. doi: 10.1093/tropej/fmh104. Epub 2005 Apr 14.
4
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.青蒿琥酯+阿莫地喹和青蒿琥酯+磺胺多辛-乙胺嘧啶用于治疗刚果民主共和国非复杂性疟疾:一项测定磺胺多辛和乙胺嘧啶耐药单倍型的临床试验
Trop Med Int Health. 2006 Oct;11(10):1503-11. doi: 10.1111/j.1365-3156.2006.01710.x.
5
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.巴布亚新几内亚针对恶性疟原虫、间日疟原虫和三日疟原虫的标准治疗方案的寄生虫学及临床疗效
P N G Med J. 2005 Sep-Dec;48(3-4):141-50.
6
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.青蒿琥酯加阿莫地喹、青蒿琥酯加磺胺多辛-乙胺嘧啶以及氯喹加磺胺多辛-乙胺嘧啶在科摩罗联盟非复杂性恶性疟患者中的疗效。
Acta Trop. 2007 Jun;102(3):176-81. doi: 10.1016/j.actatropica.2007.03.004. Epub 2007 May 3.
7
Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.氯喹或阿莫地喹联合磺胺多辛-乙胺嘧啶治疗巴布亚新几内亚非复杂性恶性疟的疗效
P N G Med J. 2003 Sep-Dec;46(3-4):125-34.
8
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.在布基纳法索,阿莫地喹联合磺胺多辛-乙胺嘧啶、蒿甲醚-本芴醇以及双氢青蒿素-哌喹治疗无并发症恶性疟原虫疟疾的随机对照研究
Clin Infect Dis. 2007 Dec 1;45(11):1453-61. doi: 10.1086/522985. Epub 2007 Oct 22.
9
[Genetic diversity of P. falciparum and pathogenesis of the severe malarial anaemia in children under 5 years old in the province of Boulgou, Burkina Faso].[布基纳法索布尔古省5岁以下儿童恶性疟原虫的遗传多样性与严重疟疾贫血的发病机制]
Bull Soc Pathol Exot. 2006 Jul;99(3):166-70.
10
Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.蒿甲醚-本芴醇和阿莫地喹-磺胺多辛-乙胺嘧啶对尼日利亚西南部非复杂性恶性疟原虫疟疾患儿配子体携带情况的治疗效果及影响
Am J Trop Med Hyg. 2007 Aug;77(2):235-41.